Samah W. Awwad
@SamahAwwad3
Followers
161
Following
670
Media
4
Statuses
120
Postdoc @SPjacksonGroup @CRUK_CI @Cambridge_uni. Interested in #DNAdamage #Replicationstress #Genomestability
Cambridge, England
Joined January 2019
RT @EmanMassalha: Thrilled and excited to share our latest work published in #BloodJournal. We uncover how defective neutrophil clearance d….
0
2
0
RT @bokterium: “To write for impact means to keep it as simple as possible.” Good read and very insightful. https….
0
575
0
RT @Andrew_Akbashev: A BIG STUDY in Nature Medicine:.Which food makes you age faster?. Scientists looked at 105,000 people in 30 years. The….
0
304
0
RT @SPJacksonGroup: Excited to share our preprint, work spearheaded by PhD student @jordancjwilson with Marciniak Lab @TheCIMR, @villunger….
0
5
0
Great opportunity and great mentor!.
🚨 Fully funded #PhD opportunity! 🚨. Passionate about cancer research? Join @MadziaCrossley's team to investigate how R-loop dysregulation contributes to cancer. 📍 Cambridge, UK.💰 Fully funded.📅 Apply by 24 March 2025.
0
0
2
RT @SPJacksonGroup: Don't miss this opportunity to learn about #CRISPR from world experts including Thijn Brummelkamp @NKI_nl, @durocher1,….
0
6
0
RT @SPJacksonGroup: This exciting novel discovery, published in @NatureComms, with contributions from the Balasubramanian lab @ChemCambridg….
0
3
0
Huge thanks to our amazing collaborators for their essential contributions! #CancerResearch #ATR #SyntheticLethality.
1
0
0
Happy to share our newly published article in Nature Communications! In this work, we uncover the novel role of KLF5 in sensitizing cells to ATR inhibition, identifying it as a synthetic lethal partner with the tumor suppressor ARID1A. @SPJacksonGroup .
4
12
57
RT @SPJacksonGroup: Now out in @GenomeMedicine @BioMedCentral. Transform your #crispr screens with "Exorcise", EXOme-guided Re-annotation o….
0
10
0
RT @SPJacksonGroup: We are recruiting for a Research Assistant (Computing) (Fixed Term) @Cambridge_Uni Please share.
0
4
0
RT @SPJacksonGroup: Two exciting opportunities for suitably qualified postgraduates/postdocs to join the Steve Jackson lab at the world ren….
0
14
0
RT @Nathaniel_Mabe: With 3 approved epigenetic drug classes and many more under clinical investigation, epigenetic targets are gaining tra….
0
73
0
RT @embojournal: SUMO/ubiquitin E3 ligase #TOPORS promotes #decitabine tolerance by removal of DNMT1-DNA crosslinks; while dCMP deaminase D….
0
6
0
RT @LabLegube: Deadline for the roscoff transcription and genome maintenance has been extended to may 21th!👇.
0
7
0